[Results of the use of ticlid in the treatment of patients with post-thrombotic retinopathy].
Presents 22 case histories of patients with postthrombotic retinopathy (n = 20) and fresh thrombosis (n = 2), treated with ticlid, a new drug. Demonstrates the disaggregating and antithrombotic effects of the drug, a positive time course of microcirculatory changes in the fundus oculi and improvement of blood rheology.